Add like
Add dislike
Add to saved papers

A survey of the incidence of defibrillator damage during double sequential external defibrillation for refractory ventricular fibrillation.

Resuscitation plus. 2022 September
BACKGROUND: Double Sequential External Defibrillation (DSED) is a proposed treatment strategy for patients in refractory VF (RVF) during out-of-hospital cardiac arrest (OHCA). Defibrillator damage employing DSED is a theoretical concern expressed by defibrillator manufacturers yet the incidence of damage during resuscitation remains unknown.

OBJECTIVE: We sought to explore the incidence of defibrillator damage employing DSED for RVF during OHCA.

METHODS: We conducted a survey of EMS agencies, authors of previous publications, EMS medical directors, base hospital medical oversight groups, and defibrillator manufacturers to assess the incidence of defibrillator damage during DSED. Our survey focused on the frequency of DSED use, number of shocks used during DSED, technique used to employ DSED (simultaneous or sequential), and the incidence of defibrillator damage during DSED. We specifically targeted groups that were known to be using DSED in clinical practice.

RESULTS: Our survey response rate was 50% (65/129): 61% (34/56) EMS medical directors, 60% (6/10) authors, 100% (8/8) base hospitals, 33% (1/3) defibrillator manufacturers, 31% (16/52) paramedic services. In our case-based analysis the overall incidence of defibrillator damage was 0.4%. The incidence of defibrillator damage based on total number of DSED shocks was estimated between 0.11% and 0.22%. All reported cases of defibrillator damage occurred using a simultaneous defibrillation technique.

CONCLUSION: When DSED is employed using either a sequential or simultaneous technique the rate of defibrillator damage appears to be exceedingly low. Further high-quality evidence is required to determine the impact of DSED on patient centered outcomes, but the incidence of defibrillator damage should not limit it use. Defibrillator damage should continue to be monitored in future trials and clinical practice.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app